<DOC>
	<DOC>NCT01560624</DOC>
	<brief_summary>This study is an international, multicenter, randomized (1:1 oral treprostinil (UT-15C): placebo), double-blind, placebo-controlled study in subjects with Pulmonary Arterial Hypertension (PAH) who are currently receiving background oral monotherapy for at least 30 days at randomization for their PAH. Study visits will occur in four week intervals for the first 12 weeks, then every 12 weeks thereafter with key measures of efficacy being time to first clinical worsening event and the 6-minute walk test at Week 24. Study procedures include routine blood tests, medical history, physical exams, disease evaluation, and exercise tests. Patients who complete all required assessments will also be eligible to enter a long-term, open-label, extension study (TDE-PH-311).</brief_summary>
	<brief_title>Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Treprostinil</mesh_term>
	<criteria>1. Between 18 and 75 years of age, inclusive 2. PAH that is idiopathic / heritable, PAH associated with connective tissue disease, HIV infection, repaired congenital systemictopulmonary shunts (repaired &gt; 1 year), or appetite suppressant / toxin use 3. Receiving one PAHapproved oral therapy at an appropriate dose 4. Previous testing (e.g. right heart catheterization, echocardiography) consistent with diagnosis of PAH 1. Nursing or pregnant 2. PAH due to conditions other than noted in the above inclusion criteria 3. History of uncontrolled sleep apnea, severe liver disease, left sided heart disease, uncontrolled systemic hypertension 4. Use of an investigational drug or device within 30 days of Screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>PAH</keyword>
	<keyword>PH</keyword>
	<keyword>Clinical Worsening</keyword>
	<keyword>Freedom</keyword>
	<keyword>Freedom-Ev</keyword>
	<keyword>Treprostinil</keyword>
	<keyword>UT-15C</keyword>
	<keyword>6 Minute walk test</keyword>
</DOC>